These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 38646646)
1. Nanotechnology in inflammation: cutting-edge advances in diagnostics, therapeutics and theranostics. Liu Y; Lin Z; Wang Y; Chen L; Wang Y; Luo C Theranostics; 2024; 14(6):2490-2525. PubMed ID: 38646646 [TBL] [Abstract][Full Text] [Related]
2. Emerging nanotherapeutics for antithrombotic treatment. Zhao Z; Yang F; Zhang X; Sun J; He Z; Luo C Biomaterials; 2020 Oct; 255():120200. PubMed ID: 32563945 [TBL] [Abstract][Full Text] [Related]
3. Nanotherapeutics for Antimetastatic Treatment. Yang F; Zhao Z; Sun B; Chen Q; Sun J; He Z; Luo C Trends Cancer; 2020 Aug; 6(8):645-659. PubMed ID: 32448754 [TBL] [Abstract][Full Text] [Related]
4. Unveiling Green Synthesis and Biomedical Theranostic paradigms of Selenium Nanoparticles (SeNPs) - A state-of-the-art comprehensive update. Nag S; Kar S; Mishra S; Stany B; Seelan A; Mohanto S; Haryini S S; Kamaraj C; Subramaniyan V Int J Pharm; 2024 Sep; 662():124535. PubMed ID: 39094922 [TBL] [Abstract][Full Text] [Related]
5. Boarding pyroptosis onto nanotechnology for cancer therapy. Ban W; Chen Z; Zhang T; Du T; Huo D; Zhu G; He Z; Sun J; Sun M J Control Release; 2024 Jun; 370():653-676. PubMed ID: 38735396 [TBL] [Abstract][Full Text] [Related]
6. Advances in Atherosclerosis Theranostics Harnessing Iron Oxide-Based Nanoparticles. Wang S; He H; Mao Y; Zhang Y; Gu N Adv Sci (Weinh); 2024 May; 11(17):e2308298. PubMed ID: 38368274 [TBL] [Abstract][Full Text] [Related]
7. Current Trends in Nanotheranostics: A Concise Review on Bioimaging and Smart Wearable Technology. Sharma AK Nanotheranostics; 2023; 7(3):258-269. PubMed ID: 37064611 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in cell membrane camouflaged nanotherapeutics for the treatment of bacterial infection. Jia Y; Zhang L; Xu J; Xiang L Biomed Mater; 2024 May; 19(4):. PubMed ID: 38697197 [TBL] [Abstract][Full Text] [Related]
9. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives. Ma Y; Huang J; Song S; Chen H; Zhang Z Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247 [TBL] [Abstract][Full Text] [Related]
10. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders. Hassanzadeh P; Atyabi F; Dinarvand R Life Sci; 2017 Aug; 182():93-103. PubMed ID: 28583367 [TBL] [Abstract][Full Text] [Related]
11. Nanotheranostics, a future remedy of neurological disorders. Sharma M; Dube T; Chibh S; Kour A; Mishra J; Panda JJ Expert Opin Drug Deliv; 2019 Feb; 16(2):113-128. PubMed ID: 30572726 [TBL] [Abstract][Full Text] [Related]
12. High-density lipoprotein mimetic nano-therapeutics targeting monocytes and macrophages for improved cardiovascular care: a comprehensive review. Zhen J; Li X; Yu H; Du B J Nanobiotechnology; 2024 May; 22(1):263. PubMed ID: 38760755 [TBL] [Abstract][Full Text] [Related]
13. Nanoparticle theranostics in cardiovascular inflammation. MacRitchie N; Di Francesco V; Ferreira MFMM; Guzik TJ; Decuzzi P; Maffia P Semin Immunol; 2021 Aug; 56():101536. PubMed ID: 34862118 [TBL] [Abstract][Full Text] [Related]
14. Two-Dimensional Nanomaterials for Cancer Nanotheranostics. Chen Y; Wu Y; Sun B; Liu S; Liu H Small; 2017 Mar; 13(10):. PubMed ID: 28075057 [TBL] [Abstract][Full Text] [Related]
15. Inflammation targeted nanomedicines: Patents and applications in cancer therapy. Praveen TK; Gangadharappa HV; Abu Lila AS; Moin A; Mehmood K; Krishna KL; Hussain T; Alafnan A; Shakil S; Rizvi SMD Semin Cancer Biol; 2022 Nov; 86(Pt 2):645-663. PubMed ID: 35405339 [TBL] [Abstract][Full Text] [Related]
16. Theranostics - a sure cure for cancer after 100 years? Song Y; Zou J; Castellanos EA; Matsuura N; Ronald JA; Shuhendler A; Weber WA; Gilad AA; Müller C; Witney TH; Chen X Theranostics; 2024; 14(6):2464-2488. PubMed ID: 38646648 [TBL] [Abstract][Full Text] [Related]
17. Nanomedicine: an emerging era of theranostics and therapeutics for rheumatoid arthritis. Qamar N; Arif A; Bhatti A; John P Rheumatology (Oxford); 2019 Oct; 58(10):1715-1721. PubMed ID: 31377812 [TBL] [Abstract][Full Text] [Related]
18. Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy. Lorkowski ME; Atukorale PU; Ghaghada KB; Karathanasis E Adv Healthc Mater; 2021 Mar; 10(5):e2001044. PubMed ID: 33225633 [TBL] [Abstract][Full Text] [Related]
19. Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases. Kim KS; Song CG; Kang PM Antioxid Redox Signal; 2019 Feb; 30(5):733-746. PubMed ID: 29228781 [TBL] [Abstract][Full Text] [Related]
20. Green Synthesized Nanomaterials as Theranostic Platforms for Cancer Treatment: Principles, Challenges and the Road Ahead. Rajasekharreddy P; Huang C; Busi S; Rajkumari J; Tai MH; Liu G Curr Med Chem; 2019; 26(8):1311-1327. PubMed ID: 28294042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]